Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Oct 31, 2023 | (FY)Oct 31, 2022 | (FY)Oct 31, 2021 | (FY)Oct 31, 2020 | (FY)Oct 31, 2019 | (FY)Oct 31, 2018 | (FY)Oct 31, 2017 | (FY)Oct 31, 2016 | (FY)Oct 31, 2015 | (FY)Oct 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 321.43%1.86B | -494.13%-841.93M | -121.29%-141.71M | -48.20%665.53M | 700.51%1.28B | 332.99%160.49M | -106.31%-68.88M | 4,494.29%1.09B | -102.92%-24.86M | 11,759.23%850.78M |
Net profit before non-cash adjustment | 71.89%1.25B | 83.45%724.87M | 358.63%395.13M | -122.72%-152.78M | -21.48%672.3M | 6.04%856.23M | 71.12%807.47M | -36.21%471.88M | 3.72%739.71M | -24.63%713.14M |
Total adjustment of non-cash items | -0.46%177.86M | 394.51%178.67M | -125.00%-60.67M | 358.26%242.69M | 3.62%-93.97M | 33.29%-97.5M | -650.11%-146.15M | 128.46%26.57M | -426.97%-93.37M | 145.57%28.56M |
-Depreciation and amortization | 33.90%539.38M | 183.47%402.83M | 13.31%142.11M | 39.55%125.41M | -4.89%89.87M | 2.36%94.49M | -4.49%92.31M | -2.70%96.64M | -8.82%99.33M | 14.62%108.94M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --147.7M | ---- | ---- | ---- | --63.97M | ---- | --62M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 92.02%-1.71M | 47.54%-21.44M | -312.94%-40.88M |
-Disposal profit | -149.42%-197.44M | -103.46%-79.16M | -292.43%-38.91M | 376.88%20.22M | ---7.3M | ---- | -10.56%-5.13M | 92.86%-4.64M | -1,178.17%-64.94M | 106.30%6.02M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 316.31%42.02M | 80.86%10.09M | --5.58M |
-Other non-cash items | -13.16%-164.08M | 11.51%-145M | -223.61%-163.87M | 71.32%-50.64M | 8.05%-176.54M | 17.72%-191.99M | -37.48%-233.33M | -45.80%-169.72M | -2.92%-116.4M | -39.24%-113.11M |
Changes in working capital | 125.23%440.4M | -266.56%-1.75B | -182.72%-476.17M | -18.52%575.61M | 218.09%706.44M | 18.07%-598.23M | -222.93%-730.2M | 188.50%594.01M | -715.31%-671.2M | 112.45%109.08M |
-Change in receivables | -60.99%-322.08M | 75.11%-200.06M | -164.47%-803.77M | 123.97%1.25B | 289.70%556.69M | 53.78%-293.46M | -295.11%-634.96M | 46.71%325.44M | 2,472.88%221.83M | 101.21%8.62M |
-Change in inventory | 115.95%204.18M | -482.74%-1.28B | -304.96%-219.7M | -62.47%107.19M | 162.99%285.61M | 5.95%-453.41M | -220.64%-482.11M | 154.47%399.61M | -2,887.28%-733.68M | 94.48%-24.56M |
-Change in payables | -152.63%-93.96M | -63.54%178.51M | 163.39%489.55M | -439.61%-772.24M | -263.35%-143.11M | -81.65%87.61M | 312.45%477.47M | -199.11%-224.75M | -247.21%-75.14M | -83.35%51.04M |
-Provision for loans, leases and other losses | -90.92%-13.24M | -155.74%-6.94M | 816.13%12.44M | -45.87%1.36M | -89.51%2.51M | 501.41%23.92M | ---5.96M | ---- | ---- | ---- |
-Changes in other current assets | 201.75%391.48M | -51,333.69%-384.77M | -97.45%751K | 167.87%29.42M | 138.81%10.98M | 111.60%4.6M | -417.15%-39.63M | -18.89%12.5M | 252.39%15.41M | 54.40%-10.11M |
-Changes in other current liabilities | 627.85%274.01M | -216.50%-51.91M | 220.59%44.56M | -491.42%-36.95M | -119.22%-6.25M | 172.23%32.52M | -155.43%-45.02M | 181.51%81.21M | -218.48%-99.63M | 3,130.20%84.09M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -2.21%-58.2M | -27.22%-56.94M | -52.17%-44.76M | -24.01%-29.41M | -8.50%-23.72M | -0.10%-21.86M | 2.08%-21.84M | 9.58%-22.3M | 1.13%-24.67M | -8.85%-24.95M |
Interest received (cash flow from operating activities) | 24.20%222.1M | -5.21%178.83M | 26.31%188.66M | -14.78%149.36M | -0.69%175.26M | 5.82%176.48M | 12.07%166.78M | 2.46%148.81M | 4.98%145.23M | 27.58%138.34M |
Tax refund paid | -8.68%-162.91M | -386.00%-149.91M | 83.25%-30.85M | -13.51%-184.11M | 14.01%-162.2M | -750.50%-188.62M | 114.52%29M | 8.09%-199.7M | 47.38%-217.27M | 14.91%-412.88M |
Other operating cash inflow (outflow) | 0 | 0.00%-1K | -1K | 0 | 0.00%-1K | 0.00%-1K | 0.00%-1K | 0.00%-1K | -1K | 0 |
Operating cash flow | 314.41%1.87B | -2,936.15%-869.95M | -104.76%-28.65M | -52.80%601.37M | 907.23%1.27B | 20.41%126.5M | -89.69%105.05M | 938.46%1.02B | -122.05%-121.57M | 240.44%551.29M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 96.16%-42.4M | 57.43%-1.1B | -144.39%-2.59B | 62.38%-1.06B | -4,455.19%-2.82B | -59.19%-61.92M | -114.10%-38.9M | 84.95%275.79M | 669.11%149.12M | 24.52%-26.2M |
Net intangibles purchase and sale | 16.89%-48.49M | -128.62%-58.35M | 18.43%-25.52M | 38.77%-31.29M | -52.72%-51.1M | -102.00%-33.46M | -160.83%-16.57M | -544.77%-6.35M | 94.15%-985K | 50.66%-16.85M |
Net business purchase and sale | --33.96M | --0 | ---- | ---- | ---- | ---- | --92.19M | ---- | ---- | ---- |
Net investment product transactions | 98.22%-11.5M | -0.35%-646.58M | -484.05%-644.35M | 155.43%167.78M | -17,884.79%-302.68M | 95.56%-1.68M | 91.30%-37.93M | -5,709.30%-435.99M | -419.77%-7.51M | -30.38%2.35M |
Net changes in other investments | -93.57%7.29M | 22.00%113.38M | 148.67%92.93M | -299.20%-190.93M | 228.21%95.85M | 55.98%-74.76M | -16,983,600.00%-169.84M | 0.00%-1K | -200.00%-1K | --1K |
Investing cash flow | 96.39%-61.15M | 46.52%-1.7B | -184.18%-3.17B | 63.76%-1.12B | -1,691.68%-3.08B | -0.46%-171.82M | -2.69%-171.03M | -218.44%-166.55M | 445.49%140.63M | 37.85%-40.7M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -122.04%-486.76M | -34.03%2.21B | 423.13%3.35B | -76.47%640M | 837.93%2.72B | 384.21%290M | -118.55%-102.04M | 623.81%550M | -133.33%-105M | -126.61%-45M |
Net common stock issuance | -575.00%-27K | ---4K | --0 | 0.02%-149.98M | 40.75%-150M | -59.87%-253.16M | 28.02%-158.35M | -488,768.89%-219.99M | -50.00%-45K | -3.45%-30K |
Cash dividends paid | 0.02%-148.22M | 0.33%-148.24M | 1.79%-148.73M | 3.30%-151.45M | -1.90%-156.62M | 4.33%-153.71M | 3.89%-160.67M | 0.29%-167.18M | -0.25%-167.67M | -20.00%-167.26M |
Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.09%-6.18M | -85.41%-7.93M |
Net other fund-raising expenses | 196.07%587K | 75.21%-611K | 97.90%-2.47M | -7,918.16%-117.47M | -0.07%-1.47M | -298.91%-1.46M | -112.34%-367K | --2.97M | ---- | 50.00%-1K |
Financing cash flow | -130.80%-634.42M | -35.57%2.06B | 1,345.80%3.2B | -90.83%221.11M | 2,138.27%2.41B | 71.92%-118.33M | -354.18%-421.43M | 159.45%165.8M | -26.64%-278.89M | -966.33%-220.22M |
Net cash flow | ||||||||||
Beginning cash position | -25.70%1.46B | 0.57%1.97B | -13.03%1.96B | 37.00%2.25B | -9.06%1.64B | -21.26%1.81B | 71.71%2.29B | -15.78%1.34B | 23.03%1.59B | -24.64%1.29B |
Current changes in cash | 331.32%1.17B | -25,373.40%-505.65M | 99.32%-1.99M | -148.24%-293.06M | 471.20%607.5M | 66.42%-163.66M | -147.85%-487.41M | 492.00%1.02B | -189.48%-259.83M | 167.12%290.37M |
Effect of exchange rate changes | --636K | --0 | ---- | ---- | ---- | ---- | ---- | -214.31%-11.02M | 48.60%9.64M | -42.25%6.49M |
Cash adjustments other than cash changes | ---- | ---- | --13.13M | ---- | 200.00%1K | ---1K | ---- | -4,985,500.00%-49.85M | 200.00%1K | -200.00%-1K |
End cash Position | 80.05%2.63B | -25.70%1.46B | 0.57%1.97B | -13.03%1.96B | 37.00%2.25B | -9.06%1.64B | -21.26%1.81B | 71.71%2.29B | -15.78%1.34B | 23.03%1.59B |
Free cash flow | 187.27%1.77B | 23.25%-2.03B | -438.97%-2.65B | 69.26%-491.26M | -5,343.19%-1.6B | -38.44%30.48M | -94.99%49.51M | 764.68%987.76M | -129.27%-148.61M | 210.04%507.74M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |